Get This Daily Newsletter by Email

Health & Welfare Plans Newsletter

November 7, 2025

BenefitsLink.com logo
EmployeeBenefitsJobs.com logo

💼  New Job Opportunity Today

 

[Guidance Overview]

Developments in Bringing Most-Favored-Nation Pricing to American Patients

"President Donald J. Trump announced ... agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk to dramatically reduce the prices Americans pay for some of the world's most popular drugs."  MORE >>

Executive Office of the President

[Guidance Overview]

New Pricing Agreements Aim to Lower Costs of Popular Weight Loss Drugs

"Slated for 2026, President Trump's direct-to-consumer TrumpRx website will offer obesity drugs to Americans for as low as $150 for a month's supply. This announcement marks one of the first major actions to enforce MFN, or Most-Favored-Nation, pricing in an executive order signed in May."  MORE >>

OneDigital

[Guidance Overview]

Agencies Clarify How Certain Fertility Benefits May Be Treated as Excepted Benefits

"The Agencies also announced that they intend to propose notice and comment rulemaking to provide additional ways that certain fertility benefits may be offered as a limited excepted benefit if certain conditions are met and are considering whether to modify the standards under which supplemental health insurance coverage provided by a group health plan, including a supplemental benefit for fertility coverage, will be considered to satisfy the conditions for being an excepted benefit."  MORE >>

Woodruff Sawyer

[Guidance Overview]

Do We Still Have to Comply with the HIPAA Privacy Rule to Support Reproductive Health Care? (PDF)

"[C]overed entities and business associates do not need to update HIPAA policies and procedures, risk assessments, business associate agreements, and training for the 2024 Privacy Rule. Covered entities and business associates who took actions to comply with the 2024 Privacy Rule before the nationwide injunction was issued should consult legal counsel regarding further actions."  MORE >>

Thomson Reuters / EBIA

[Guidance Overview]

New York City Employers: Changes Required by Amendments to Increase Earned Safe and Sick Time Act

"The Earned Sick and Safe Time Act has been expanded to [1] formally codify the paid prenatal leave requirements into the local law, [2] provide for additional unpaid time, and [3] permit more reasons for use of time."  MORE >>

Jackson Lewis P.C.

[Guidance Overview]

New Safe and Sick Leave Requirements in New York City

"The ESSTA amendments now require employers to provide a separate bank of at least 32 hours of unpaid leave that must be front-loaded at hire and at the beginning of each calendar year.... Employers must now provide 20 hours of paid prenatal leave during any 52-week calendar period in accordance with the other ESSTA parameters. The effect of this codification is that the ESSTA's strong enforcement actions now include enforcing compliance with paid prenatal leave requirements."  MORE >>

Venable LLP

Employers Face Pressure from Soaring Drug Prices

"An analysis of more than 190 employers and over 190,000 members found that overall pharmacy spend has increased by roughly 18% per member per month compared to the prior year. With specialty medications driving up costs and limited transparency from pharmacy benefit managers (PBMs), employers are increasingly seeking new strategies to manage expenses while ensuring that employees maintain access to essential medications."  MORE >>

IMA Financial Group

[Opinion]

No Swords, No Subsidies: Let the Market Set Drug Prices

"While the list prices of these drugs are $1,000 per month, both Lilly and Novo Nordisk have already been selling them to cash-paying patients at lower prices.... This shows what happens when third-party payers don't distort the market's natural price feedback loop."  MORE >>

Cato Institute

Benefits in General

DOL Advisory Opinion Challenged in Court

"The Sheresky plaintiffs allege that Morgan Stanley improperly lobbied the DOL in an 'ex parte process' for over a year ... They further allege that Morgan Stanley is impermissibly utilizing the Advisory Opinion in the arbitrations to argue that because the DOL's 'official position' is that the Program is not governed by ERISA, the financial advisors' claims are frivolous and must be dropped, and that Morgan Stanley will seek attorneys' fees if the arbitrations proceed." [Sheresky v. Chaves-DeRemer, No. 25-8935 (S.D.N.Y. complaint filed Oct. 28, 2025)]  MORE >>

Miller & Chevalier

Employee Benefits Jobs

💼

Regional Vice President, Sales

MAP Retirement USA LLC

Remote

View job as Regional Vice President, Sales for MAP Retirement USA LLC

Press Releases

LRS Announces Sponsorship of FlowerHire Cannabis HR Leadership Summit at MjBizCon

Leading Retirement Solutions

Benefitfocus Health Insights Collaborates with Deerhold to Advance Price Transparency in Healthcare

Benefitfocus

Last Issue's Most Popular Items

District Court Vacates ACA Section 1557 Gender-Identity Discrimination Rules

Thomson Reuters / EBIA

DOL Releases Guidance on Fertility Coverage

Slevin & Hart, P.C.

Draft of 2026 IRS Publication 15-A: Employer's Supplemental Tax Guide (PDF)

Internal Revenue Service [IRS]

Unsubscribe  |   Change Email Address

Search Past Issues   |   Privacy Policy

Submit an Article   |   Contact Us   |   Advertise Here

Copyright 2025 BenefitsLink.com, Inc. All materials contained in this newsletter are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of BenefitsLink.com, Inc., or in the case of third party materials, the owner of those materials. You may not alter or remove any trademark, copyright or other notices from copies of the content.

BenefitsLink® Health & Welfare Plans Newsletter, ISSN no. 1536-9595.

Links to web sites other than BenefitsLink.com and EmployeeBenefitsJobs.com are offered as a service to our readers. We are not involved in their production and are not responsible for their content.